REG - CVS Group plc - Appointment of Non-executive Chair

CVSAnnouncement

01/05/2024 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240501:nRSA6857Ma&default-theme=true

RNS Number : 6857M  CVS Group plc  01 May 2024

For immediate release
 
       1 May 2024

 

CVS Group plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

 

Appointment of Non-executive Chair

 

CVS, the UK listed veterinary group and a leading provider of veterinary
services, announces the appointment of David Wilton as Chair with effect from
1 May 2024.

 

David has served as an Independent Non-executive Director of the Company since
September 2021.

 

David is a qualified Chartered Accountant with more than 30 years'
post-qualification experience as a Chief Financial Officer, Non-Executive
Director (NED), Chair and consultant after many years in corporate finance,
primarily in mid-cap M&A with Rothschilds. David has held roles in both
public and private-equity backed companies including as CFO of Sumo Group plc,
Group Finance Director of WYG plc and NED and Chair of the Audit Committee of
Sweett Group plc. David was NED and subsequently Chair at Frontier
Developments plc until November 2023. David is currently also NED and Chair
Designate at Gateley (Holdings) plc. He has extensive experience of people
businesses and of regulatory processes. David also brings to the Chair role a
significant amount of technical expertise, which will support CVS in its
strategic delivery of investment in technology.

 

David Wilton's appointment follows a comprehensive search by the Nomination
Committee, supported by a blue chip recruitment firm who sourced a number of
high quality candidates.

 

The Board would like to thank Deborah Kemp, the Group's Senior Independent
Director who has been acting as Interim Chair during the search period.

 

The Board is committed to high standards of corporate governance and will
commence a search for a new Independent Audit Committee Chair. David will
remain as Audit Committee Chair until this process is completed, at which
point he will then step down as a member of the Audit Committee.

 

David Wilton, Non-executive Chair, commented: "I am delighted to take on the
role of Chair. I know the business well and I look forward to supporting the
executive management team even more closely as we continue to grow the
business and deliver value for all of our stakeholders."

 

Richard Fairman, CEO, commented: "On behalf of the Board and colleagues at
CVS, I would like to congratulate David on his appointment as Chair, and thank
Deborah for her contribution during her position as Interim Chair."

 

CVS Group
plc
        via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Joint Broker)
                    +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark / Lalit Bose

 

  Berenberg (Joint
Broker)
        +44 (0)20 3207 7800

Toby Flaux / Ben Wright / James Thompson / Milo Bonser

 

Camarco (Financial
PR)

Ginny Pulbrook
                                            +44 (0)7961
315 138

Geoffrey Pelham-Lane
                                       +44 (0)7733 124
226

 

   About CVS Group plc (www.cvsukltd.co.uk (http://www.cvsukltd.co.uk) )

 

CVS Group is an AIM-listed provider of veterinary services with operations in
the UK, Australia, the Netherlands and the Republic of Ireland.  CVS is
focused on providing high-quality clinical services to its clients and their
animals, with outstanding and dedicated clinical teams and support colleagues
at the core of its strategy.

 

The Group operates c.500 veterinary practices across its four territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties), Crematoria
(providing pet cremation and clinical waste disposal for CVS and third-party
practices) and the Group's online retail business ("Animed Direct").

 

The Group employs c.9,100 personnel, including c.2,400 veterinary surgeons and
c.3,400 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAZZGFDVGMGDZM